Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-26

FDA Approved: DUTASTERIDE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved Epic Pharma's supplemental application to bring a generic dutasteride product to market for the treatment of benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)

Snippet

SUPPL AP for DUTASTERIDE (DUTASTERIDE)